CHARACTERISTICS ASSOCIATED WITH LONG-TERM MAINTENANCE OF SINUS RHYTHM AFTER PULMONARY VEINS ISOLATION

2019 ◽  
Vol 25 (2) ◽  
pp. 115-119
Author(s):  
Azamat M. Baymukanov ◽  
I. A Khamnagadaev ◽  
S. A Termosesov ◽  
I. L Ilyich ◽  
G. E Gendlin ◽  
...  

Atrial fibrillation is the most frequent supraventricular tachyarrhythmia. Pulmonary veins isolation can be performed as the first line of treatment for this arrhythmia. Unfortunately, approximately 30% of patients in the first year after ablation have recurrence of atrial fibrillation. In this regard, we have attempted to identify the characteristics associated with long-term maintenance of sinus rhythm after pulmonary veins isolation.

2016 ◽  
Vol 22 (1) ◽  
pp. 3-19 ◽  
Author(s):  
Jonathan W. Waks ◽  
Peter Zimetbaum

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and affects over 33 million people worldwide. AF is associated with stroke and systemic thromboembolism, unpleasant symptoms and reduced quality of life, heart failure, and increased mortality, and treatment of AF and its complications are associated with significant cost. Antiarrhythmic drugs (AADs) can suppress AF, allowing long-term maintenance of sinus rhythm, and have the potential to relieve symptoms and reverse or prevent adverse effects associated with AF. However, large randomized controlled studies evaluating use of AADs have not demonstrated a clear benefit to maintaining sinus rhythm, and AADs often have significant limitations, including a modest rate of overall success at maintaining sinus rhythm, frequent side effects, and potentially life-threatening toxicities. Although some of the currently available AADs have been available for almost 100 years, better tolerated and more efficacious AADs have recently been developed both for long-term maintenance of sinus rhythm and for chemical cardioversion of AF to sinus rhythm. Advances in automated AF detection with cardiac implantable electronic devices have suggested that AADs might be useful for suppressing AF to allow safe discontinuation of anticoagulation in select patients who are in sinus rhythm for prolonged periods of time. AADs may also have synergistic effects with catheter ablation of AF. This review summarizes the pharmacology and clinical use of currently available AADs for treatment of AF and discusses novel AADs and future directions for rhythm control in AF.


2004 ◽  
Vol 94 (12) ◽  
pp. 1563-1566 ◽  
Author(s):  
George E. Kochiadakis ◽  
Nikos E. Igoumenidis ◽  
Michail E. Hamilos ◽  
Panagiotis G. Tzerakis ◽  
Nikos C. Klapsinos ◽  
...  

Heart Rhythm ◽  
2009 ◽  
Vol 6 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Felipe Atienza ◽  
Jesús Almendral ◽  
José Jalife ◽  
Sharon Zlochiver ◽  
Robert Ploutz-Snyder ◽  
...  

CHEST Journal ◽  
2004 ◽  
Vol 125 (2) ◽  
pp. 377-383 ◽  
Author(s):  
George E. Kochiadakis ◽  
Nikos E. Igoumenidis ◽  
Michail I. Hamilos ◽  
Panos G. Tzerakis ◽  
Nikos C. Klapsinos ◽  
...  

Author(s):  
Andy C. Kiser ◽  
Mark D. Landers ◽  
Ker Boyce ◽  
Matjaž šinkovec ◽  
Andrej Pernat ◽  
...  

Objective Transmural and contiguous ablations and a comprehensive lesion pattern are difficult to create from the surface of a beating heart but are critical to the successful treatment of persistent, isolated atrial fibrillation. A codisciplinary simultaneous epicardial (surgical) and endocardial (catheter) procedure (Convergent procedure) addresses these issues. Methods Patients with symptomatic atrial fibrillation who failed medical treatment were evaluated. Using only pericardioscopy, the surgeon performed near-complete epicardial isolation of the pulmonary veins and a “box” lesion on the posterior left atrium using unipolar radiofrequency ablation. Simultaneous endocardial catheter radiofrequency ablation completed pulmonary vein isolation, performed a mitral annular and cavotricuspid isthmus line of block, and debulked the coronary sinus. Twelve-month results for the Convergent procedure were compared with 12-month results for concomitant and pericardioscopic (stand-alone transdiaphragmatic/thoracoscopic) atrial fibrillation procedures using unipolar radiofrequency ablation. Results Sixty-five patients underwent the Convergent procedure (mean age, 62 y; mean body surface area, 2.17 m2; mean atrial fibrillation duration, 4.8 y; mean left atrial size, 5.2 cm). Ninety-two percent were in persistent or long-standing persistent atrial fibrillation. At 12 months, evaluation with 24-hour Holter monitors found 82% of patients in sinus rhythm, while only 47% of pericardioscopic and 77% of concomitant patients treated with unipolar radiofrequency ablation were in sinus rhythm. Conclusions Simultaneous epicardial and endocardial ablation improves outcomes for patients with persistent or longstanding persistent atrial fibrillation. This successful collaboration between cardiac surgeon and electrophysiologist is an important treatment option for patients with large left atriums and chronic atrial fibrillation.


Sign in / Sign up

Export Citation Format

Share Document